ClinicalTrials.gov
ClinicalTrials.gov Menu

GALLANT 2 Tesaglitazar vs. Placebo

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00252772
Recruitment Status : Terminated (The development program has been terminated)
First Posted : November 15, 2005
Last Update Posted : April 22, 2009
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Terminated
  Primary Completion Date : No date given
  Actual Study Completion Date : November 2006